Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

[Perioperative cardiovascular evaluation and management for noncardiac surgery].

Furuichi Y, Sakamoto A.

Masui. 2014 Mar;63(3):287-95. Review. Japanese.

PMID:
24724438
2.

Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.

Schouten O, Poldermans D, Visser L, Kertai MD, Klein J, van Urk H, Simoons ML, van de Ven LL, Vermeulen M, Bax JJ, Lameris TW, Boersma E.

Am Heart J. 2004 Dec;148(6):1047-52. No abstract available.

PMID:
15632892
3.

Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).

Dunkelgrun M, Boersma E, Schouten O, Koopman-van Gemert AW, van Poorten F, Bax JJ, Thomson IR, Poldermans D; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.

Ann Surg. 2009 Jun;249(6):921-6. doi: 10.1097/SLA.0b013e3181a77d00.

PMID:
19474688
4.

[Multicenter study of cardiac events and anesthetic management of patients with ischemic heart diseases undergoing noncardiac surgery].

Yamada T, Nomura M, Iwade M, Omi A, Kashimoto S, Yoshioka H, Kikuchi T, Fujimoto K, Honda O, Seki M, Ishiguro T, Takeda J.

Masui. 2000 Jun;49(6):673-9. Japanese.

PMID:
10885253
5.

The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.

Juul AB, Wetterslev J, Kofoed-Enevoldsen A, Callesen T, Jensen G, Gluud C; Diabetic Postoperative Mortality and Morbidity group.

Am Heart J. 2004 Apr;147(4):677-83.

PMID:
15077084
6.

beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review.

Auerbach AD, Goldman L.

JAMA. 2002 Mar 20;287(11):1435-44. Review.

PMID:
11903031
7.

Perioperative beta blockade in noncardiac surgery: a review of the literature.

Mason KE, Davis LL.

AANA J. 2006 Apr;74(2):113-7. Review.

PMID:
16617914
8.

Assessment and management of patients with ischemic heart disease.

Akhtar S, Silverman DG.

Crit Care Med. 2004 Apr;32(4 Suppl):S126-36. Review.

PMID:
15064671
9.

[Beta-blocker therapy and risk reduction in non-cardiac surgery].

Passamonti E, Pirelli S.

Ital Heart J Suppl. 2003 Feb;4(2):96-101. Review. Italian.

PMID:
12762258
10.

Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Wijeysundera DN, Duncan D, Nkonde-Price C, Virani SS, Washam JB, Fleischmann KE, Fleisher LA; ACC/AHA Task Force Members.

Circulation. 2014 Dec 9;130(24):2246-64. doi: 10.1161/CIR.0000000000000104. Epub 2014 Aug 1. Review.

11.

Use of beta-blockade to prevent death after noncardiac surgery.

Wallace A, Mangano DT.

West J Med. 1997 Mar;166(3):203-4. No abstract available.

12.
13.

[Perioperaive evaluation and management in vascular surgery especially for arteriosclerosis obliterans].

Inoue Y, Iwai T.

Nihon Geka Gakkai Zasshi. 2005 May;106(5):344-8. Review. Japanese.

PMID:
15934552
14.

The use of beta-blockers to decrease adverse perioperative cardiac events.

Ryder DL.

Dimens Crit Care Nurs. 2008 Mar-Apr;27(2):47-53. Review.

PMID:
18510181
15.

[Beta-blockers in patients undergoing noncardiac surgery: implications of the POISE study].

Alonso-Coello P, Alvarez C, Cruz P, Torán L, De Nadal M, Martínez M, Paniagua P, Mases A, Urrutia G; Grupo de Trabajoj POISE-Espana.

Rev Esp Anestesiol Reanim. 2009 Apr;56(4):232-8. Spanish. No abstract available.

PMID:
19537263
17.

[Organprotection in cardiac risk patients--rational of perioperative beta-adrenoceptor-antagonists and statins].

Hanss R, Bein B.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2010 Apr;45(4):246-52; quiz 253. doi: 10.1055/s-0030-1253093. Epub 2010 Apr 12. Review. German.

PMID:
20387182
18.

Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up.

Zaugg M, Bestmann L, Wacker J, Lucchinetti E, Boltres A, Schulz C, Hersberger M, Kälin G, Furrer L, Hofer C, Blumenthal S, Müller A, Zollinger A, Spahn DR, Borgeat A.

Anesthesiology. 2007 Jul;107(1):33-44.

19.

The experts debate: perioperative beta-blockade for noncardiac surgery--proven safe or not?

Poldermans D, Devereaux PJ.

Cleve Clin J Med. 2009 Nov;76 Suppl 4:S84-92. doi: 10.3949/ccjm.76.s4.14.

PMID:
20064814
20.

Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients.

Fleisher LA, Corbett W, Berry C, Poldermans D.

J Cardiothorac Vasc Anesth. 2004 Feb;18(1):7-13.

PMID:
14973792

Supplemental Content

Support Center